MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches
The deeper understanding of non-coding RNAs has recently changed the dogma of
molecular biology assuming protein-coding genes as unique functional biological effectors …
molecular biology assuming protein-coding genes as unique functional biological effectors …
Metabolic regulation of histone post-translational modifications
Histone post-translational modifications regulate transcription and other DNA-templated
functions. This process is dynamically regulated by specific modifying enzymes whose …
functions. This process is dynamically regulated by specific modifying enzymes whose …
Epigenetic regulation by histone demethylases in hypoxia
RL Hancock, K Dunne, LJ Walport, E Flashman… - …, 2015 - Taylor & Francis
The response to hypoxia is primarily mediated by the hypoxia-inducible transcription factor
(HIF). Levels of HIF are regulated by the oxygen-sensing HIF hydroxylases, members of the …
(HIF). Levels of HIF are regulated by the oxygen-sensing HIF hydroxylases, members of the …
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription
R Kaukonen, A Mai, M Georgiadou, M Saari… - Nature …, 2016 - nature.com
Tissue homeostasis is dependent on the controlled localization of specific cell types and the
correct composition of the extracellular stroma. While the role of the cancer stroma in tumour …
correct composition of the extracellular stroma. While the role of the cancer stroma in tumour …
Regulatory networks of LncRNA MALAT-1 in cancer
S Fu, Y Wang, H Li, L Chen, Q Liu - Cancer management and …, 2020 - Taylor & Francis
Long noncoding (lnc) RNAs are a group of RNAs with a length greater than 200 nt that do
not encode a protein but play an essential role in regulating the expression of target genes …
not encode a protein but play an essential role in regulating the expression of target genes …
Advances in histone demethylase KDM3A as a cancer therapeutic target
J Yoo, YH Jeon, HY Cho, SW Lee, GW Kim, DH Lee… - Cancers, 2020 - mdpi.com
Lysine-specific histone demethylase 3 (KDM3) subfamily proteins are H3K9me2/me1
histone demethylases that promote gene expression. The KDM3 subfamily primarily consists …
histone demethylases that promote gene expression. The KDM3 subfamily primarily consists …
Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α
High aerobic glycolysis not only provides energy to cancer cells, but also supports their
anabolic growth. JMJD1A, a histone demethylase that specifically demethylates …
anabolic growth. JMJD1A, a histone demethylase that specifically demethylates …
Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival
The histone demethylase JMJD1A, which controls gene expression by epigenetic regulation
of H3K9 methylation marks, functions in diverse activities, including spermatogenesis …
of H3K9 methylation marks, functions in diverse activities, including spermatogenesis …
Crucial functions of the JMJD1/KDM3 epigenetic regulators in cancer
Y Sui, R Gu, R Janknecht - Molecular Cancer Research, 2021 - AACR
Epigenetic changes are one underlying cause for cancer development and often due to
dysregulation of enzymes modifying DNA or histones. Most Jumonji C domain-containing …
dysregulation of enzymes modifying DNA or histones. Most Jumonji C domain-containing …
The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer
MA Wade, D Jones, L Wilson, J Stockley… - Nucleic acids …, 2015 - academic.oup.com
Endocrine therapy has successfully been used to treat estrogen receptor (ER)-positive
breast cancer, but this invariably fails with cancers becoming refractory to treatment …
breast cancer, but this invariably fails with cancers becoming refractory to treatment …